This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1991 Apr:31:S24-8.

Atherosclerosis and lipid disorders after renal transplantation

T B Drüeke¹, Z Abdulmassih, B Lacour, C Bader, A Chevalier, H Kreis

Affiliations

PMID: 2046266

Review

Atherosclerosis and lipid disorders after renal transplantation

T B Drüeke et al. Kidney Int Suppl. 1991 Apr.

. 1991 Apr:31:S24-8.

Authors

T B Drüeke¹, Z Abdulmassih, B Lacour, C Bader, A Chevalier, H Kreis

Affiliation

¹ INSERM Unit 90, Département de Néphrologie, Hôpital Necker, Paris, France.

PMID: 2046266

No abstract available

PubMed Disclaimer

Similar articles

[Lipid metabolism and atherosclerosis risk in renal diseases in pediatric age].
Ferrara P, Ruggiero A, Pulitanò S, Vacca P, Venuti L, Salvaggio E. Ferrara P, et al. Minerva Pediatr. 1998 Dec;50(12):513-8. Minerva Pediatr. 1998. PMID: 10210942 Review. Italian.
[Atherosclerosis and arteriosclerosis of the small vessels in chronic renal insufficiency and after transplantation: lipid factors].
Boizel R. Boizel R. Nephrologie. 2000;21(7):329-32. Nephrologie. 2000. PMID: 11200602 Review. French.
Hyperlipidaemia after renal transplantation.
[No authors listed] [No authors listed] Lancet. 1988 Apr 23;1(8591):919-20. Lancet. 1988. PMID: 2895837 Review. No abstract available.
Lipid lowering therapy in atherosclerosis.
Aikawa M, Libby P. Aikawa M, et al. Semin Vasc Med. 2004 Nov;4(4):357-66. doi: 10.1055/s-2004-869592. Semin Vasc Med. 2004. PMID: 15861316 Review.
[Which lipid parameters are atherogenic? Pathological lipid values and their therapeutic consequences].
Thomas HP, Steinhagen-Thiessen E. Thomas HP, et al. MMW Fortschr Med. 1999 Sep 16;141(37):34-6. MMW Fortschr Med. 1999. PMID: 10897971 German.

See all similar articles

Cited by

High plasma levels of oxidatively modified low-density lipoproteins are associated with the suppressed expression of immunomodulatory molecules in patients with hematological malignancies.
Yang HQ, Qiu FQ, Jin KE, Jiang NG, Zhang LI. Yang HQ, et al. Exp Ther Med. 2015 Jun;9(6):2394-2400. doi: 10.3892/etm.2015.2392. Epub 2015 Mar 27. Exp Ther Med. 2015. PMID: 26136994 Free PMC article.
Efficacy of simvastatin in children with hyperlipidemia secondary to kidney disorders.
García-de-la-Puente S, Arredondo-García JL, Gutiérrez-Castrellón P, Bojorquez-Ochoa A, Maya ER, Pérez-Martínez Mdel P. García-de-la-Puente S, et al. Pediatr Nephrol. 2009 Jun;24(6):1205-10. doi: 10.1007/s00467-009-1128-7. Epub 2009 Feb 24. Pediatr Nephrol. 2009. PMID: 19238452 Clinical Trial.
Cardiovascular risk factors and diseases after renal transplantation.
Aker S, Ivens K, Grabensee B, Heering P. Aker S, et al. Int Urol Nephrol. 1998;30(6):777-88. doi: 10.1007/BF02564867. Int Urol Nephrol. 1998. PMID: 10195874
Post-transplant dyslipidemia: Mechanisms, diagnosis and management.
Agarwal A, Prasad GV. Agarwal A, et al. World J Transplant. 2016 Mar 24;6(1):125-34. doi: 10.5500/wjt.v6.i1.125. World J Transplant. 2016. PMID: 27011910 Free PMC article. Review.
The effect of fluvastatin of hyperlipidemia in renal transplant recipients: a prospective, placebo-controlled study.
Türk S, Yildiz A, Tükek T, Akkaya V, Aras U, Türkmen A, Uras AR, Sever MS. Türk S, et al. Int Urol Nephrol. 2001;32(4):713-6. doi: 10.1023/a:1015052312866. Int Urol Nephrol. 2001. PMID: 11989571 Clinical Trial.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Medical
- MedlinePlus Health Information